Andrew Stone

10PUBLICATIONS
61CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 17, 2025
Extracellular vesicle bioactivity and potential for clinical development are determined by mesenchymal stromal cell clonal subtype.

Savvas Ioannou, Alasdair G Kay, Andrew P Stone

|Sep 12, 2025
Induction of moderate DNA damage enhances megakaryopoiesis and platelet production.

Virginia Camacho, Roelof H Bekendam, Andrew P Stone

|Dec 16, 2024
Inhibition of RhoA-mediated secretory autophagy in megakaryocytes mitigates myelofibrosis in mice.

Isabelle C Becker, Maria N Barrachina, Joshua Lykins

|Jun 17, 2024
Extracellular matrices of stromal cell subtypes regulate phenotype and contribute to the stromal microenvironment in vivo.

Andrew P Stone, Emma Rand, Gabriel Thornes

|Mar 24, 2024
SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow.

Isabelle Allaeys, Guillaume Lemaire, Mickaël Leclercq

|Nov 09, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.

Abdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat

Pageof 2